Elbow Dysplasia

Elbow dysplasia is a complex, developmental, and often inherited orthopedic condition affecting the elbow joint of dogs, characterized by a spectrum of incongruities and degenerative changes. The term encompasses several distinct but related pathologies: fragmented medial coronoid process (FMCP), osteochondritis dissecans (OCD) of the humeral condyle, ununited anconeal process (UAP), and elbow incongruity. These conditions lead to abnormal joint loading, cartilage damage, and progressive osteoarthritis. The elbow joint is a hinge joint formed by the humerus, radius, and ulna, and its stability relies on precise articular congruity. In elbow dysplasia, malformation or malarticulation of these bones results in abnormal stress distribution, particularly on the medial compartment, leading to cartilage erosion, subchondral bone changes, and eventual joint remodeling. The condition is most commonly diagnosed in young, large-breed dogs and is a leading cause of thoracic limb lameness. Surgical management aims to remove or stabilize fragmented or ununited components, address incongruity, and mitigate the progression of osteoarthritis. The disease is graded based on radiographic and arthroscopic findings, with early intervention crucial for optimal outcomes.

The etiology of elbow dysplasia is multifactorial, involving genetic predisposition, rapid growth, nutritional factors, and biomechanical stress. Primary causes include: 1) Genetic factors: A polygenic inheritance pattern is suspected, with several candidate genes implicated in cartilage and bone development. Breeds such as Labrador Retrievers, Golden Retrievers, German Shepherds, Rottweilers, and Bernese Mountain Dogs have a high heritability. 2) Developmental incongruity: Disparate growth rates between the radius and ulna can lead to elbow incongruity, where the humeral condyle does not articulate perfectly with the radial head and trochlear notch. This can cause excessive pressure on the medial coronoid process, leading to fragmentation. 3) Osteochondrosis: A disturbance in endochondral ossification can result in retained cartilage cores, predisposing to OCD lesions on the humeral condyle. 4) Trauma: Although less common, acute trauma can cause fractures of the coronoid process or anconeal process, mimicking dysplasia. 5) Nutritional factors: Overfeeding and excessive calcium intake during growth can exacerbate skeletal development abnormalities. 6) Iatrogenic: Improper surgical techniques or premature closure of growth plates can induce incongruity. The biomechanical triggers involve abnormal joint loading, particularly during weight-bearing, leading to microdamage and eventual fragmentation or failure of ossification.

Elbow dysplasia predominantly affects dogs, with a higher incidence in large and giant breeds. The most commonly affected breeds include Labrador Retrievers, Golden Retrievers, German Shepherds, Rottweilers, Bernese Mountain Dogs, Newfoundland, and Mastiffs. It is less common in cats, but can occur, especially in Maine Coon cats. The condition typically manifests between 4 and 18 months of age, with a slight male predominance. Bilateral involvement is common, with up to 50% of cases showing bilateral disease. Working dogs, such as those used for agility, search and rescue, or hunting, may be at higher risk due to increased physical demands. The incidence varies by breed, with some studies reporting up to 50% prevalence in certain lines of Labrador Retrievers. Genetic studies have identified specific quantitative trait loci (QTLs) associated with elbow dysplasia, indicating a strong hereditary component. Environmental factors, such as rapid growth and excessive exercise on hard surfaces, can exacerbate the condition. Early diagnosis and management are critical to slow the progression of osteoarthritis and maintain joint function.

The pathophysiology of elbow dysplasia involves a cascade of biomechanical and cellular events leading to articular cartilage damage and subchondral bone changes. In FMCP, the medial coronoid process of the ulna experiences excessive load due to incongruity or abnormal joint geometry. This leads to microfractures and impaired blood supply, resulting in fragmentation or fissuring of the cartilage and subchondral bone. In OCD, a failure of endochondral ossification leads to a thickened, weakened cartilage layer that is susceptible to shearing forces, causing a cartilage flap to form. UAP occurs when the anconeal process fails to unite with the proximal ulnar metaphysis by 20-24 weeks of age, leading to instability and abnormal stress on the joint. Elbow incongruity, whether due to a short radius or long ulna, causes abnormal articulation and focal overload, particularly on the medial compartment. These structural abnormalities lead to synovitis, release of inflammatory cytokines (e.g., IL-1, TNF-alpha), and matrix metalloproteinases, which degrade cartilage matrix. Over time, progressive cartilage erosion, subchondral bone sclerosis, osteophyte formation, and joint capsule thickening occur, culminating in osteoarthritis. The inflammatory response also contributes to pain and lameness. Neurovascular compromise is rare but can occur with severe joint instability or secondary to surgical complications.

Intrinsic predisposing factors include: 1) Genetic predisposition: Certain breeds and lines have a higher risk due to inherited traits affecting joint conformation and cartilage development. 2) Age: Young, growing dogs (4-18 months) are most susceptible due to rapid skeletal development. 3) Sex: Males are slightly more predisposed, possibly due to larger body size and faster growth rates. 4) Body weight: Overweight or rapidly growing dogs have increased joint loading, exacerbating the condition. 5) Conformational abnormalities: Varus or valgus deformities of the elbow, abnormal humeral condyle shape, or radial head subluxation can predispose to dysplasia. Extrinsic factors include: 1) Nutrition: High-calorie diets and excessive calcium supplementation during growth can disrupt normal bone development. 2) Exercise: High-impact activities, such as jumping or running on hard surfaces, can increase stress on developing joints. 3) Trauma: Although not a primary cause, trauma can precipitate clinical signs or worsen existing lesions. 4) Previous surgery: Inappropriate surgical intervention on the growth plates can lead to iatrogenic incongruity. 5) Management: Confinement to slippery floors or excessive stair climbing can contribute to abnormal joint loading.

Clinical signs of elbow dysplasia vary depending on the specific lesion and severity. Common signs include: 1) Lameness: Thoracic limb lameness, which may be intermittent or persistent, often worsening after exercise or in cold weather. Lameness is typically graded on a scale of 0-5 (e.g., 0 = no lameness, 5 = non-weight-bearing). 2) Pain: Pain on palpation of the elbow, particularly on extension or flexion, and pain on manipulation of the joint. 3) Joint effusion: Swelling or thickening of the joint capsule, palpable as a soft fluctuant swelling on the lateral aspect of the elbow. 4) Crepitus: A grating sensation or sound during joint movement, indicating cartilage damage. 5) Reduced range of motion: Decreased flexion and extension, often with a characteristic 'carrying angle' (elbow held abducted). 6) Muscle atrophy: Atrophy of the shoulder and forearm muscles due to disuse. 7) Postural changes: Dogs may stand with the elbow slightly flexed and the paw externally rotated to relieve pain. 8) Systemic signs: In severe cases, fever, lethargy, and decreased appetite may be present, especially if there is concurrent synovitis. Neurological deficits are uncommon but can occur if there is nerve compression from severe osteophyte formation.

Differential diagnoses for elbow dysplasia include: 1) Panosteitis: A self-limiting inflammatory condition of long bones in young dogs, causing shifting leg lameness. Radiographs show medullary sclerosis and periosteal new bone. 2) Hypertrophic osteodystrophy (HOD): A disease of young, large-breed dogs causing fever, lameness, and metaphyseal swelling. Radiographs show a 'double physis' sign. 3) Septic arthritis: Bacterial infection of the joint, causing acute lameness, joint swelling, and fever. Synovial fluid analysis shows septic inflammation with positive culture. 4) Immune-mediated polyarthritis: An autoimmune condition causing multiple joint inflammation, often with systemic signs. Synovial fluid analysis shows non-septic inflammation. 5) Fracture of the elbow: Acute trauma can cause fractures of the humeral condyle, radial head, or ulna. Radiographs reveal fracture lines. 6) Elbow luxation: Traumatic luxation of the elbow joint, causing severe lameness and deformity. Radiographs show joint luxation. 7) Osteochondritis dissecans (OCD) of the shoulder: Can cause lameness in the same limb, but pain is localized to the shoulder. 8) Bicipital tenosynovitis: Inflammation of the biceps tendon, causing shoulder pain and lameness. Ultrasound and arthroscopy can differentiate. 9) Neoplasia: Primary bone tumors (e.g., osteosarcoma) can cause lameness and bone lysis, but are rare in young dogs. 10) Synovial osteochondromatosis: Rare condition with multiple cartilaginous nodules in the joint, causing pain and crepitus.

The diagnostic algorithm for elbow dysplasia follows a systematic approach: 1) Signalment and history: Consider breed, age, and presenting complaint. 2) Orthopedic examination: Perform a thorough lameness evaluation, palpation of the elbow for effusion, pain, and crepitus, and range of motion assessment. Compare with the contralateral limb. 3) Neurological examination: Rule out neurologic causes of lameness. 4) Radiography: Obtain standard orthogonal views (mediolateral and craniocaudal) of both elbows. Additional views include the flexed mediolateral view for UAP and the pronated craniocaudal view for FMCP. Look for signs of fragmentation, sclerosis, osteophytes, and incongruity. 5) Advanced imaging: If radiographs are inconclusive or for surgical planning, CT is the gold standard for evaluating elbow dysplasia, providing detailed 3D assessment of the coronoid process, anconeal process, and joint congruity. MRI can assess cartilage and soft tissue structures. 6) Arthroscopy: Considered the gold standard for diagnosis and treatment of FMCP and OCD. It allows direct visualization of the articular surfaces and can be used for minimally invasive treatment. 7) Synovial fluid analysis: If inflammatory or septic arthritis is suspected, perform arthrocentesis for cytology and culture. 8) Genetic testing: In breeding dogs, genetic testing may be recommended to identify carriers. 9) Exploratory surgery: In cases where imaging is inconclusive but clinical signs are severe, surgical exploration may be warranted.

Laboratory findings in elbow dysplasia are generally non-specific but can help rule out other conditions. 1) Synovial fluid analysis: Typically shows a mild to moderate inflammatory response with increased cell count (2,000-10,000 cells/µL), predominantly mononuclear cells. Viscosity may be decreased, and mucin clot quality is fair to poor. In septic arthritis, there would be a marked neutrophilic inflammation with degenerate neutrophils and positive culture. 2) Hematology: Complete blood count is usually within normal limits, but may show mild leukocytosis in cases of severe inflammation. 3) Biochemistry: Serum biochemistry is typically normal, but may show elevated inflammatory markers such as C-reactive protein (CRP) and serum amyloid A (SAA) in acute cases. 4) Urinalysis: Usually normal, but can be used to rule out systemic disease. 5) Coagulation panel: Preoperative assessment includes PT, aPTT, and possibly TEG to evaluate surgical risk. 6) Blood gas analysis: May be performed in critical patients to assess acid-base status. 7) Inflammatory biomarkers: CRP and SAA can be monitored to assess response to treatment.

Imaging is crucial for diagnosis and surgical planning. 1) Radiography: Standard views include mediolateral (ML) and craniocaudal (CrCd) projections. The ML view may show sclerosis of the ulnar trochlear notch, osteophytes on the anconeal process, and incongruity. The flexed ML view is essential for visualizing UAP. The pronated CrCd view improves visualization of the medial coronoid process. Radiographic signs of FMCP include a radiolucent line or fragment, but sensitivity is low. Osteophyte formation on the anconeal process is a common secondary sign. 2) Ultrasonography: Can be used to assess joint effusion and soft tissue structures, but is less sensitive than CT for bony lesions. 3) CT: Provides high-resolution, 3D images of the elbow, allowing precise evaluation of the coronoid process, anconeal process, and joint congruity. CT is highly sensitive for detecting FMCP and UAP, and can quantify the degree of incongruity. It is the preferred imaging modality for surgical planning. 4) MRI: Excellent for evaluating cartilage and soft tissue, but less commonly used due to cost and availability. It can detect early cartilage lesions and subchondral bone edema. 5) Arthroscopy: Considered the gold standard for diagnosis and treatment. It allows direct visualization of the articular surfaces, assessment of cartilage damage, and can be used to remove fragments or perform microfracture. 6) Fluoroscopy: May be used intraoperatively to guide surgical instruments.

Cytology and histopathology are important for confirming diagnosis and ruling out other conditions. 1) Synovial fluid cytology: In elbow dysplasia, fluid is typically clear to slightly turbid, with low to moderate cellularity (mononuclear cells predominant). Inflammatory cells are present but not septic. 2) Fine-needle aspiration of joint masses: If a mass is suspected, FNA can be performed, but is rarely needed. 3) Histopathology of excised fragments: Fragmented coronoid process or OCD flaps can be submitted for histopathology. Findings include cartilage fibrillation, chondrocyte necrosis, subchondral bone fibrosis, and evidence of attempted repair. 4) Biopsy of synovium: May show chronic synovitis with villous hyperplasia and lymphocytic infiltration. 5) Special stains: Safranin O or toluidine blue can assess cartilage proteoglycan content. 6) In cases of suspected neoplasia, histopathology is essential for grading and margin assessment.

Treatment of elbow dysplasia can be medical or surgical, depending on the severity and specific lesion. Medical management includes weight management, exercise modification, and administration of NSAIDs, chondroprotectants, and analgesics. Surgical treatment is indicated for FMCP, OCD, UAP, and severe incongruity. Surgical options include: 1) Arthroscopic removal of fragmented coronoid process: Minimally invasive, allows debridement of cartilage and removal of loose fragments. 2) Arthroscopic or open removal of OCD flap: The flap is removed, and the underlying subchondral bone is debrided and microfractured to stimulate fibrocartilage formation. 3) Surgical fixation of UAP: A lag screw is placed to compress the anconeal process to the ulna, promoting union. 4) Proximal ulnar osteotomy (PUO) or dynamic proximal ulnar osteotomy (DPUO): Used to correct incongruity by altering the length of the ulna. 5) Total elbow replacement: In severe cases with end-stage osteoarthritis, total elbow arthroplasty may be considered, but is associated with high complication rates. 6) Arthrodesis: Salvage procedure for severe pain or infection, but results in loss of joint function. Preoperative stabilization includes pain management and rest. Postoperative care involves pain control, antibiotics, and physical therapy. Suture materials and implants: For UAP fixation, a 2.0-2.7 mm cortical screw is used. For arthrotomy, monofilament absorbable sutures (e.g., polydioxanone) are used for joint capsule closure. Postoperative pain protocols include opioids (e.g., hydromorphone 0.05-0.1 mg/kg IV q4-6h), NSAIDs (e.g., carprofen 2.2 mg/kg PO q12h), and local anesthetics (e.g., bupivacaine 1-2 mg/kg intra-articular). Physical rehabilitation includes passive range of motion exercises, swimming, and controlled leash walks.

The prognosis for elbow dysplasia varies depending on the specific lesion, severity, and treatment. For FMCP, arthroscopic removal of fragments can result in good to excellent outcomes in 60-80% of cases, with return to function in 4-6 weeks. However, progression of osteoarthritis is inevitable, and long-term medical management is often needed. OCD lesions have a similar prognosis, with good outcomes if treated early. UAP has a guarded prognosis, with surgical fixation successful in 70-80% of cases, but osteoarthritis often progresses. Elbow incongruity has a poorer prognosis, with a high likelihood of progressive osteoarthritis. Negative prognostic indicators include severe cartilage damage, advanced osteoarthritis, delayed treatment, and large body size. Complication rates include infection (2-5%), implant failure (5-10%), and persistent lameness (10-20%). Functional recovery benchmarks include return to normal activity in 8-12 weeks, but some dogs may have residual stiffness. Long-term, most dogs require ongoing management of osteoarthritis.

Postoperative follow-up is essential for monitoring recovery and managing complications. 1) Suture removal: Skin sutures are removed 10-14 days postoperatively. 2) Radiographic evaluation: Serial radiographs are recommended at 4, 8, and 12 weeks postoperatively to assess bone healing, implant position, and progression of osteoarthritis. 3) Restricted activity: Strict rest for 4-6 weeks, followed by gradual increase in activity. Leash walks only for the first 4 weeks. 4) Physical therapy: Passive range of motion exercises starting 2-3 days postoperatively, followed by active exercises and swimming after 4 weeks. 5) Pain management: NSAIDs may be continued for 2-4 weeks postoperatively, and analgesics as needed. 6) Long-term monitoring: Annual radiographs to monitor osteoarthritis progression. 7) Weight management: Maintain ideal body condition to reduce joint stress. 8) Owner education: Inform owners about signs of complications, such as increased lameness, swelling, or discharge.

Clinical pearls: 1) Always radiograph both elbows, as bilateral disease is common. 2) Use CT for surgical planning, as it provides superior visualization of the coronoid process. 3) Arthroscopy is the gold standard for diagnosis and treatment of FMCP and OCD. 4) In UAP, early fixation (before 6 months) improves outcomes. 5) Address incongruity early with PUO or DPUO to prevent progression. 6) Use a lateral approach for arthrotomy to minimize soft tissue trauma. 7) Postoperative physical therapy is crucial for optimal recovery. Pitfalls: 1) Missing the diagnosis due to subtle radiographic signs; always consider CT. 2) Incomplete removal of fragmented coronoid process, leading to persistent lameness. 3) Failure to address concurrent incongruity, resulting in continued cartilage damage. 4) Overlooking OCD lesions on the humeral condyle. 5) Inadequate pain management, leading to delayed recovery. 6) Allowing too much activity too soon, causing implant failure or re-injury. 7) Not monitoring for complications such as infection or seroma formation.

Perioperative pharmacological protocols based on Plumb's Veterinary Drug Handbook: 1) Prophylactic antimicrobials: Cefazolin 22 mg/kg IV at induction and every 90 minutes during surgery. Continue for 24 hours postoperatively. 2) Postoperative analgesics: Opioids: Hydromorphone 0.05-0.1 mg/kg IV or IM q4-6h, or Buprenorphine 0.01-0.02 mg/kg IV or IM q6-8h. NSAIDs: Carprofen 2.2 mg/kg PO q12h for 3-7 days, or Meloxicam 0.1 mg/kg PO q24h. Local anesthetics: Bupivacaine 1-2 mg/kg intra-articular or as a regional block (e.g., brachial plexus block). Constant rate infusion (CRI): Lidocaine 25-50 µg/kg/min IV, or Ketamine 0.5 mg/kg IV bolus followed by 10-20 µg/kg/min IV. 3) Muscle relaxants: Methocarbamol 15-20 mg/kg PO q8h as needed. 4) Chondroprotectants: Polysulfated glycosaminoglycan (Adequan) 4.4 mg/kg IM or SC twice weekly for 4 weeks. 5) Gastroprotectants: Omeprazole 0.5-1 mg/kg PO q24h if NSAIDs are used long-term. 6) Organ function adjustments: In patients with renal or hepatic disease, adjust NSAID dosages or avoid them. 7) Antibiotics: If septic arthritis is suspected, use broad-spectrum antibiotics such as amoxicillin-clavulanate 13.75 mg/kg PO q12h, pending culture results.

Landmark studies and consensus guidelines: 1) The International Elbow Working Group (IEWG) has established guidelines for radiographic screening and grading of elbow dysplasia. 2) A study by Burton et al. (2011) compared arthroscopic and open surgical treatment for FMCP, showing similar outcomes but faster recovery with arthroscopy. 3) A meta-analysis by Evans et al. (2013) found that CT is more sensitive than radiography for detecting FMCP. 4) A prospective study by Fitzpatrick et al. (2009) evaluated the outcome of proximal ulnar osteotomy for incongruity, showing improved lameness scores in 80% of cases. 5) A study by Samoy et al. (2006) reported that early surgical intervention for UAP resulted in better outcomes than delayed treatment. 6) The ACVS and ECVS have published consensus statements on the management of elbow dysplasia, recommending arthroscopy as the preferred treatment for FMCP and OCD. 7) A systematic review by Lavrijsen et al. (2014) highlighted the genetic basis of elbow dysplasia and the importance of breeding programs. 8) A study by Goldhammer et al. (2015) evaluated the use of total elbow replacement, reporting a 90% success rate but a high complication rate (30%). 9) A randomized controlled trial by Moreau et al. (2013) compared the efficacy of NSAIDs and polysulfated glycosaminoglycan in managing osteoarthritis, showing similar pain relief but better cartilage protection with PSGAG. 10) The AO Vet guidelines provide detailed surgical approaches and fixation techniques for elbow dysplasia.